Comparability of Prognostic Features Among Young and Old Patients
Favorable Parameter . | % Patients . | P . | ||
---|---|---|---|---|
<65 yr (N = 49) . | 65-69 yr (N = 39) . | ≥70 yr (N = 10) . | ||
Cytogenetics | 74 | 64 | 90 | .2 |
B2M ≤2.5 mg/L | 51 | 33 | 40 | .2 |
CRP ≤4.0 mg/L | 53 | 38 | 60 | .3 |
≤12 mo of prior therapy | 55 | 54 | 70 | .6 |
Non-IgA isotype | 82 | 85 | 70 | .6 |
Sensitive | 59 | 64 | 70 | .8 |
LDH ≤190 U/L | 88 | 92 | 80 | .5 |
Stage <III | 49 | 58 | 60 | .6 |
Albumin >3.5 g/dL | 51 | 46 | 40 | .8 |
Creatinine ≤2 mg/dL | 96 | 95 | 100 | .8 |
Second transplant | 76 | 69 | 50 | .3 |
CD34 >5 × 106/kg | 83 | 72 | 80 | .4 |
Favorable Parameter . | % Patients . | P . | ||
---|---|---|---|---|
<65 yr (N = 49) . | 65-69 yr (N = 39) . | ≥70 yr (N = 10) . | ||
Cytogenetics | 74 | 64 | 90 | .2 |
B2M ≤2.5 mg/L | 51 | 33 | 40 | .2 |
CRP ≤4.0 mg/L | 53 | 38 | 60 | .3 |
≤12 mo of prior therapy | 55 | 54 | 70 | .6 |
Non-IgA isotype | 82 | 85 | 70 | .6 |
Sensitive | 59 | 64 | 70 | .8 |
LDH ≤190 U/L | 88 | 92 | 80 | .5 |
Stage <III | 49 | 58 | 60 | .6 |
Albumin >3.5 g/dL | 51 | 46 | 40 | .8 |
Creatinine ≤2 mg/dL | 96 | 95 | 100 | .8 |
Second transplant | 76 | 69 | 50 | .3 |
CD34 >5 × 106/kg | 83 | 72 | 80 | .4 |